Cravatex Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 1,519.53 million compared to INR 4,199.17 million a year ago. Revenue was INR 1,653.75 million compared to INR 4,262.55 million a year ago. Net income was INR 43.23 million compared to INR 550.96 million a year ago. Basic earnings per share from continuing operations was INR 16.73 compared to INR 213.21 a year ago. Diluted earnings per share from continuing operations was INR 16.73 compared to INR 213.21 a year ago.